Theravance Biopharma Aktie
15,30
EUR
+0,50
EUR
+3,38
%
18,29
USD
+0,29
USD
+1,61
%
Werbung
Theravance Biopharma Aktie Analyse
| 16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
| 11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
| 21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung